AI and genomics: a revolution in drug discovery and development

Artificial intelligence can make drug discovery and development faster and less risky according to an industry expert, who said understanding complex diseases at the genetic level is now a possibility. Data has always been key to drug development. Pharmaceutical products are approved based on empirical evidence of safety and efficacy that is generated in preclinical experiments and clinical trials. Data is also core to the discovery process, with developers selecting candidates that have shown through experimentation that they interact with their chosen disease targets. In recent years, the way data is used for drug discovery and development has changed.